Skip to content

How It Works Pricing Blog Events Partners

Sign In Get Started →

How It Works Pricing Blog Events Partners

Sign In Get Started →

Loading people...

The OS for early-stage founders from day zero to raise.

Product

How It Works Pricing Partners

Resources

Blog Events Contact

Company

About Privacy Terms

© 2026 Startup Intros, Inc.San Francisco, CA · Made for Founders

Home
/People
/Tatiana Novobrantseva

§ Investor Profile

Tatiana Novobrantseva

Updated:Apr 2, 2026

About News Experience Investments FAQs

Quick Facts

Role: Chief Scientific Officer, Immuno-Oncology Research
Company: Moderna
Status: Active
Type: Investor

Subscribe, Save or Share

Join 25K+ founders & VCs who start their week informed.

Recent News & Mentions

Jan 1, 2018FundingModerna Therapeutics - Series G Jan 1, 2015FundingModerna - Series E Nov 1, 2013FundingModerna - Series U Dec 1, 2012FundingModerna - Series U

Experience

Chief Scientific Officer, Immuno-Oncology ResearchCurrent

Present - Present

Frequently Asked Questions

Who is Tatiana Novobrantseva?

Tatiana Novobrantseva is Chief Scientific Officer, Immuno-Oncology Research at Moderna.